Selected research
Industry Research
Chromosomal Microarray Analysis (CMA) Testing Industry Research Report 2026
Market perspective
The global Chromosomal Microarray Analysis (CMA) Testing market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Chromosomal Microarray Analysis (CMA) Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Chromosomal Microarray Analysis (CMA) Testing market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Chromosomal Microarray Analysis (CMA) Testing market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Chromosomal Microarray Analysis (CMA) Testing include Baylor Genetics, MedGenome Labs, Illumina Inc., CD Genomics, Thermo Fisher, Agilent, GeneDx, Quest Diagnostics and LabCorp, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Chromosomal Microarray Analysis (CMA) Testing market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Chromosomal Microarray Analysis (CMA) Testing.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Chromosomal Microarray Analysis (CMA) Testing Market by Company
Baylor Genetics
MedGenome Labs
Illumina Inc.
CD Genomics
Thermo Fisher
Agilent
GeneDx
Quest Diagnostics
LabCorp
Lineagen
Invitae
Centogene
Chromosomal Microarray Analysis (CMA) Testing Segment by Type
Single Nucleotide Polymorphism (SNP)
Comparative Genomic Hybridization (CGH)
Chromosomal Microarray Analysis (CMA) Testing Segment by Application
Medical
Laboratory
Clinical
Others
Chromosomal Microarray Analysis (CMA) Testing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chromosomal Microarray Analysis (CMA) Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Chromosomal Microarray Analysis (CMA) Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chromosomal Microarray Analysis (CMA) Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Chromosomal Microarray Analysis (CMA) Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Single Nucleotide Polymorphism (SNP)
- Comparative Genomic Hybridization (CGH)
Applications
- Medical
- Laboratory
- Clinical
- Others
Companies covered
- Baylor Genetics
- MedGenome Labs
- Illumina Inc.
- CD Genomics
- Thermo Fisher
- Agilent
- GeneDx
- Quest Diagnostics
- LabCorp
- Lineagen
- Invitae
- Centogene
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Chromosomal Microarray Analysis (CMA) Testing by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Single Nucleotide Polymorphism (SNP)
- 2.2.3 Comparative Genomic Hybridization (CGH)
- 2.3 Chromosomal Microarray Analysis (CMA) Testing by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Medical
- 2.3.3 Laboratory
- 2.3.4 Clinical
- 2.3.5 Others
- 2.4 Assumptions and Limitations
3 Chromosomal Microarray Analysis (CMA) Testing Breakdown Data by Type
- 3.1 Global Chromosomal Microarray Analysis (CMA) Testing Historic Market Size by Type (2021-2026)
- 3.2 Global Chromosomal Microarray Analysis (CMA) Testing Forecasted Market Size by Type (2027-2032)
4 Chromosomal Microarray Analysis (CMA) Testing Breakdown Data by Application
- 4.1 Global Chromosomal Microarray Analysis (CMA) Testing Historic Market Size by Application (2021-2026)
- 4.2 Global Chromosomal Microarray Analysis (CMA) Testing Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Chromosomal Microarray Analysis (CMA) Testing Market Perspective (2021-2032)
- 5.2 Global Chromosomal Microarray Analysis (CMA) Testing Growth Trends by Region
- 5.2.1 Global Chromosomal Microarray Analysis (CMA) Testing Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Chromosomal Microarray Analysis (CMA) Testing Historic Market Size by Region (2021-2026)
- 5.2.3 Chromosomal Microarray Analysis (CMA) Testing Forecasted Market Size by Region (2027-2032)
- 5.3 Chromosomal Microarray Analysis (CMA) Testing Market Dynamics
- 5.3.1 Chromosomal Microarray Analysis (CMA) Testing Industry Trends
- 5.3.2 Chromosomal Microarray Analysis (CMA) Testing Market Drivers
- 5.3.3 Chromosomal Microarray Analysis (CMA) Testing Market Challenges
- 5.3.4 Chromosomal Microarray Analysis (CMA) Testing Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Chromosomal Microarray Analysis (CMA) Testing Players by Revenue
- 6.1.1 Global Top Chromosomal Microarray Analysis (CMA) Testing Players by Revenue (2021-2026)
- 6.1.2 Global Chromosomal Microarray Analysis (CMA) Testing Revenue Market Share by Players (2021-2026)
- 6.2 Global Chromosomal Microarray Analysis (CMA) Testing Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Chromosomal Microarray Analysis (CMA) Testing Head Office and Area Served
- 6.4 Global Chromosomal Microarray Analysis (CMA) Testing Players, Product Type & Application
- 6.5 Global Chromosomal Microarray Analysis (CMA) Testing Manufacturers Established Date
- 6.6 Global Chromosomal Microarray Analysis (CMA) Testing Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Chromosomal Microarray Analysis (CMA) Testing Market Size (2021-2032)
- 7.2 North America Chromosomal Microarray Analysis (CMA) Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Chromosomal Microarray Analysis (CMA) Testing Market Size by Country (2021-2026)
- 7.4 North America Chromosomal Microarray Analysis (CMA) Testing Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Chromosomal Microarray Analysis (CMA) Testing Market Size (2021-2032)
- 8.2 Europe Chromosomal Microarray Analysis (CMA) Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Chromosomal Microarray Analysis (CMA) Testing Market Size by Country (2021-2026)
- 8.4 Europe Chromosomal Microarray Analysis (CMA) Testing Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Chromosomal Microarray Analysis (CMA) Testing Market Size (2021-2032)
- 9.2 Asia-Pacific Chromosomal Microarray Analysis (CMA) Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Chromosomal Microarray Analysis (CMA) Testing Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Chromosomal Microarray Analysis (CMA) Testing Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Chromosomal Microarray Analysis (CMA) Testing Market Size (2021-2032)
- 10.2 South America Chromosomal Microarray Analysis (CMA) Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Chromosomal Microarray Analysis (CMA) Testing Market Size by Country (2021-2026)
- 10.4 South America Chromosomal Microarray Analysis (CMA) Testing Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Chromosomal Microarray Analysis (CMA) Testing Market Size (2021-2032)
- 11.2 Middle East & Africa Chromosomal Microarray Analysis (CMA) Testing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Chromosomal Microarray Analysis (CMA) Testing Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Chromosomal Microarray Analysis (CMA) Testing Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Baylor Genetics
- 12.1.1 Baylor Genetics Company Information
- 12.1.2 Baylor Genetics Business Overview
- 12.1.3 Baylor Genetics Revenue in Chromosomal Microarray Analysis (CMA) Testing Business (2021-2026)
- 12.1.4 Baylor Genetics Chromosomal Microarray Analysis (CMA) Testing Product Portfolio
- 12.1.5 Baylor Genetics Recent Developments
- 12.2 MedGenome Labs
- 12.2.1 MedGenome Labs Company Information
- 12.2.2 MedGenome Labs Business Overview
- 12.2.3 MedGenome Labs Revenue in Chromosomal Microarray Analysis (CMA) Testing Business (2021-2026)
- 12.2.4 MedGenome Labs Chromosomal Microarray Analysis (CMA) Testing Product Portfolio
- 12.2.5 MedGenome Labs Recent Developments
- 12.3 Illumina Inc.
- 12.3.1 Illumina Inc. Company Information
- 12.3.2 Illumina Inc. Business Overview
- 12.3.3 Illumina Inc. Revenue in Chromosomal Microarray Analysis (CMA) Testing Business (2021-2026)
- 12.3.4 Illumina Inc. Chromosomal Microarray Analysis (CMA) Testing Product Portfolio
- 12.3.5 Illumina Inc. Recent Developments
- 12.4 CD Genomics
- 12.4.1 CD Genomics Company Information
- 12.4.2 CD Genomics Business Overview
- 12.4.3 CD Genomics Revenue in Chromosomal Microarray Analysis (CMA) Testing Business (2021-2026)
- 12.4.4 CD Genomics Chromosomal Microarray Analysis (CMA) Testing Product Portfolio
- 12.4.5 CD Genomics Recent Developments
- 12.5 Thermo Fisher
- 12.5.1 Thermo Fisher Company Information
- 12.5.2 Thermo Fisher Business Overview
- 12.5.3 Thermo Fisher Revenue in Chromosomal Microarray Analysis (CMA) Testing Business (2021-2026)
- 12.5.4 Thermo Fisher Chromosomal Microarray Analysis (CMA) Testing Product Portfolio
- 12.5.5 Thermo Fisher Recent Developments
- 12.6 Agilent
- 12.6.1 Agilent Company Information
- 12.6.2 Agilent Business Overview
- 12.6.3 Agilent Revenue in Chromosomal Microarray Analysis (CMA) Testing Business (2021-2026)
- 12.6.4 Agilent Chromosomal Microarray Analysis (CMA) Testing Product Portfolio
- 12.6.5 Agilent Recent Developments
- 12.7 GeneDx
- 12.7.1 GeneDx Company Information
- 12.7.2 GeneDx Business Overview
- 12.7.3 GeneDx Revenue in Chromosomal Microarray Analysis (CMA) Testing Business (2021-2026)
- 12.7.4 GeneDx Chromosomal Microarray Analysis (CMA) Testing Product Portfolio
- 12.7.5 GeneDx Recent Developments
- 12.8 Quest Diagnostics
- 12.8.1 Quest Diagnostics Company Information
- 12.8.2 Quest Diagnostics Business Overview
- 12.8.3 Quest Diagnostics Revenue in Chromosomal Microarray Analysis (CMA) Testing Business (2021-2026)
- 12.8.4 Quest Diagnostics Chromosomal Microarray Analysis (CMA) Testing Product Portfolio
- 12.8.5 Quest Diagnostics Recent Developments
- 12.9 LabCorp
- 12.9.1 LabCorp Company Information
- 12.9.2 LabCorp Business Overview
- 12.9.3 LabCorp Revenue in Chromosomal Microarray Analysis (CMA) Testing Business (2021-2026)
- 12.9.4 LabCorp Chromosomal Microarray Analysis (CMA) Testing Product Portfolio
- 12.9.5 LabCorp Recent Developments
- 12.10 Lineagen
- 12.10.1 Lineagen Company Information
- 12.10.2 Lineagen Business Overview
- 12.10.3 Lineagen Revenue in Chromosomal Microarray Analysis (CMA) Testing Business (2021-2026)
- 12.10.4 Lineagen Chromosomal Microarray Analysis (CMA) Testing Product Portfolio
- 12.10.5 Lineagen Recent Developments
- 12.11 Invitae
- 12.11.1 Invitae Company Information
- 12.11.2 Invitae Business Overview
- 12.11.3 Invitae Revenue in Chromosomal Microarray Analysis (CMA) Testing Business (2021-2026)
- 12.11.4 Invitae Chromosomal Microarray Analysis (CMA) Testing Product Portfolio
- 12.11.5 Invitae Recent Developments
- 12.12 Centogene
- 12.12.1 Centogene Company Information
- 12.12.2 Centogene Business Overview
- 12.12.3 Centogene Revenue in Chromosomal Microarray Analysis (CMA) Testing Business (2021-2026)
- 12.12.4 Centogene Chromosomal Microarray Analysis (CMA) Testing Product Portfolio
- 12.12.5 Centogene Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst